Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 19 March 2021. Red Maxwell.

Executive Summary

Bigfoot Biomedical secured $57M in new funding to support the commercialization of its Bigfoot Unity System, up for US FDA clearance. The system is designed for people with type 1 and type 2 diabetes who rely on multiple daily injections and will be marketed under a bundled subscription model.

“Bigfoot has been very intentional in forging strong partnerships like those we have with Abbott, Allegheny Health Network and insulin manufacturers. These partnerships are the cornerstones to achieving robust connectivity that is the first step toward our industry’s long-range vision of interoperability.” – Red Maxwell, chief marketing officer, Bigfoot Biomedical

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT143675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel